Emerging Immunotherapy Approaches for Treating Prostate Cancer

被引:20
作者
Meng, Lingbin [1 ]
Yang, Yuanquan [1 ]
Mortazavi, Amir [1 ]
Zhang, Jingsong [2 ]
机构
[1] Ohio State Univ, Comprehens Canc Ctr, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, 12902 USF Magnolia Dr, Tampa, FL 33612 USA
关键词
immunotherapy; prostate cancer; immune checkpoint inhibitors; bispecific antibodies; CAR T cells; vaccines; cytokines; immunotherapeutic combinations; CAR-T-CELLS; IMMUNE-CHECKPOINT; DOUBLE-BLIND; PHASE-III; PLUS DOCETAXEL; CLINICAL-TRIAL; SIPULEUCEL-T; TUMOR MICROENVIRONMENT; DNA VACCINE; ANTIGEN;
D O I
10.3390/ijms241814347
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immunotherapy has emerged as an important approach for cancer treatment, but its clinical efficacy has been limited in prostate cancer compared to other malignancies. This review summarizes key immunotherapy strategies under evaluation for prostate cancer, including immune checkpoint inhibitors, bispecific T cell-engaging antibodies, chimeric antigen receptor (CAR) T cells, therapeutic vaccines, and cytokines. For each modality, the rationale stemming from preclinical studies is discussed along with outcomes from completed clinical trials and strategies to improve clinical efficacy that are being tested in ongoing clinical trials. Imperative endeavors include biomarker discovery for patient selection, deciphering resistance mechanisms, refining cellular therapies such as CAR T cells, and early-stage intervention were reviewed. These ongoing efforts instill optimism that immunotherapy may eventually deliver significant clinical benefits and expand treatment options for patients with advanced prostate cancer.
引用
收藏
页数:26
相关论文
共 186 条
[41]   Phase 1 study of PSCA-targeted chimeric antigen receptor (CAR) T cell therapy for metastatic castration-resistant prostate cancer (mCRPC). [J].
Dorff, Tanya B. ;
Blanchard, Suzette ;
Martirosyan, Hripsime ;
Adkins, Lauren ;
Dhapola, Gaurav ;
Moriarty, Aidan ;
Wagner, Jamie R. ;
Chaudhry, Ammar ;
D'Apuzzo, Massimo ;
Kuhn, Peter ;
Forman, Stephen J. ;
Priceman, Saul .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[42]  
Dorff TB, 2020, J CLIN ONCOL, V38
[43]  
Drake C., 2006, J. Clin. Oncol, V24, P2573, DOI [10.1200/jco.2006.24.18_suppl.2573, DOI 10.1200/JCO.2006.24.18_SUPPL.2573]
[44]   A phase III, randomized, double-blind trial of nivolumab or placebo combined with docetaxel for metastatic castration-resistant prostate cancer (mCRPC; CheckMate 7DX) [J].
Drake, C. G. ;
Saad, F. ;
Clark, W. R. ;
Ciprotti, M. ;
Sharkey, B. ;
Subudhi, S. K. ;
Fizazi, K. .
ANNALS OF ONCOLOGY, 2020, 31 :S546-S546
[45]   The BiTE (Bispecific T-Cell engager) platform: development and future potential of a targeted immuno-oncology therapy across Tumor Types [J].
Einsele, Hermann ;
Borghaei, Hossein ;
Orlowski, Robert Z. ;
Subklewe, Marion ;
Roboz, Gail J. ;
Zugmaier, Gerhard ;
Kufer, Peter ;
Iskander, Karim ;
Kantarjian, Hagop M. .
CANCER, 2020, 126 (14) :3192-3201
[46]   IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9 [J].
Erb, Holger H. H. ;
Langlechner, Regina V. ;
Moser, Patrizia L. ;
Handle, Florian ;
Casneuf, Tineke ;
Verstraeten, Karin ;
Schlick, Bettina ;
Schaefer, Georg ;
Hall, Brett ;
Sasser, Kate ;
Culig, Zoran ;
Santer, Frederic R. .
ENDOCRINE-RELATED CANCER, 2013, 20 (05) :677-689
[47]   Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy [J].
Farhangnia, Pooya ;
Ghomi, Shamim Mollazadeh ;
Akbarpour, Mahzad ;
Delbandi, Ali-Akbar .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[48]   CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory Toxicities [J].
Fischer, Joseph W. ;
Bhattarai, Nirjal .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[49]   Nivolumab plus docetaxel in patients with chemotherapy- nai spacing diaeresis ve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial [J].
Fizazi, Karim ;
Gonzalez Mella, Pablo ;
Castellano, Daniel ;
Minatta, Jose N. ;
Rezazadeh Kalebasty, Arash ;
Shaffer, David ;
Vazquez Limon, Juan C. ;
Sanchez Lopez, Hector M. ;
Armstrong, Andrew J. ;
Horvath, Lisa ;
Bastos, Diogo A. ;
Amin, Neha P. ;
Li, Jia ;
Unsal-Kacmaz, Keziban ;
Retz, Margitta ;
Saad, Fred ;
Petrylak, Daniel P. ;
Pachynski, Russell K. .
EUROPEAN JOURNAL OF CANCER, 2022, 160 :61-71
[50]   Dietary fat and prostate cancer progression and survival [J].
Fradet, Y ;
Meyer, F ;
Bairati, I ;
Shadmani, R ;
Moore, L .
EUROPEAN UROLOGY, 1999, 35 (5-6) :388-391